Glucotrack, Inc. Files Definitive Proxy Statement

TL;DR

Glucotrack filed its proxy statement - shareholder meeting details inside.

AI Summary

Glucotrack, Inc. filed a Definitive Proxy Statement (DEF 14A) on December 6, 2024. This filing is related to the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. The filing does not contain specific financial figures or details about upcoming proposals but serves as the official record for these important corporate communications.

Why It Matters

This filing is crucial for shareholders as it contains information about upcoming votes and company governance, allowing them to make informed decisions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial information or significant corporate events.

Key Players & Entities

• Glucotrack, Inc. (company) — Registrant
• 0001493152-24-049114 (filing_id) — Accession Number
• 20241206 (date) — Filing Date

FAQ

Key Financial Figures

• $0.001 — ce of shares of common stock, par value $0.001 per share (the “common stock&rdqu
• $25,000 — ridge an estimated fee of approximately $25,000, as well as reasonable and customary do

Filing Documents

• formdef14a.htm (DEF 14A) — 307KB
• proxycard_001.jpg (GRAPHIC) — 541KB
• proxycard_002.jpg (GRAPHIC) — 414KB
• 0001493152-24-049114.txt ( ) — 1624KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 6 PROPOSAL 1: PROPOSAL TO APPROVE, FOR PURPOSES OF COMPLYING WITH NASDAQ LISTING RULE 5635(D), THE FULL ISSUANCE OF SHARES OF COMMON STOCK ISSUABLE BY THE COMPANY UPON EXERCISE OF THE SERIES A WARRANTS AND THE SERIES B WARRANTS 7 PROPOSAL 2: APPROVAL OF REVERSE STOCK SPLIT 10 PROPOSAL 3: APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION INCREASING THE NUMBER OF OUR AUTHORIZED SHARES OF COMMON STOCK 17 PROPOSAL 4: ADJOURNMENT PROPOSAL 19 HOUSEHOLDING 19 STOCKHOLDER PROPOSALS 19 i GLUCOTRACK, INC. PROXY FOR THE SPECIAL MEETING OF STOCKHOLDERS To Be Held on January 3, 2025 The following information is furnished to each stockholder in connection with the foregoing Notice of Special Meeting of Stockholders of Glucotrack, Inc., a Delaware corporation, to be held exclusively online via the Internet on Friday, January 3, 2025, at 11:00 a.m. (Eastern time) at https://www.virtualshareholdermeeting.com/GCTK2025SM . The enclosed proxy is for use at the special meeting of stockholders (the “Special Meeting”) and any postponement or adjournment thereof. Unless the context requires otherwise, references to “Glucotrack,” “the Company,” “we,” “our,” and “us” in this Proxy Statement refer to Glucotrack, Inc. In accordance with the bylaws of the Company (as they may be amended, supplemented or otherwise modified from time to time, the “Bylaws”), the Special Meeting has been called for the following purposes: 1. To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of common stock, par value $0.001 per share (the “common stock”) issuable by the Company upon exercise of the Series A Warrants and the Series B Warrants (as defined below) (the “Issuance Proposal” or “Proposal 1”); 2. To approve an amendment

View Full Filing

View this DEF 14A filing on SEC EDGAR